COVID-19 and restrictive lung disease: A deadly combo to trip off the fine balance
-
Kamal Kant Sahu
|
drkksahu85@gmail.com
Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA, United States.
https://orcid.org/0000-0002-0382-6882
- Ajay Kumar Mishra Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA, United States. https://orcid.org/0000-0003-4862-5053
- Kevin Martin Division of Pulmonary and Critical Care, Department of Internal Medicine, Worcester, MA, United States. https://orcid.org/0000-0001-7915-6515
- Iryna Chastain Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA, United States.
Abstract
Coronavirus Disease (COVID-19) pandemic has so far led to innumerable deaths worldwide. The risk factors so far that have been most studied as poor prognostic factors are old age, individuals with multiple comorbidities and immunocompromised patients. Amongst the chronic lung diseases, most patients with COVID-19 reported so far had asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease. Herein, we discuss the significance of restrictive lung disease during the COVID-19 pandemic as a potential risk factor via an example of a patient with kyphoscoliosis who succumbed to death due to COVID-19 pneumonia.
Downloads
- Abstract views: 625
- PDF: 357
Copyright (c) 2020 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
